EVIDENCE & INSIGHTS

Latest Evidence & Insights

Explore selected evidence briefs, policy and regulatory insights, implementation perspectives, practical frameworks and emerging developments in Digital Medicine and healthcare AI.

WHAT YOU WILL FIND

The rapid development of digital technologies creates both opportunities and uncertainty for healthcare organizations, professionals, researchers and innovators.

Our resources are designed to support clearer understanding of what a technology is intended to do, what evidence supports its use, what risks and limitations should be considered, how it should be governed, and how it can be implemented and monitored responsibly in real healthcare settings.

Evidence Briefs

Concise and accessible summaries of relevant research, international guidance and emerging evidence across Digital Medicine.

Practical Frameworks & Tools

Readiness frameworks, checklists, assessment tools and implementation resources that support structured organizational decision-making, governance and responsible implementation.

Policy & Regulatory Insights

Educational analysis of policy and regulatory developments affecting artificial intelligence, medical software, digital health technologies, health data and related areas of Digital Medicine.

Implementation Insights

Practical knowledge related to governance, workflow integration, organizational readiness, workforce capability, patient safety, monitoring, evaluation and continuous improvement.

Reports & Landscape Analysis

Selected analyses of emerging developments, evidence gaps, opportunities and implementation needs relevant to Digital Medicine in Viet Nam.

Practical knowledge for informed healthcare decisions

PRIORITY THEMES

01 | Responsible AI & Medical Software

Evidence, intended use, risk assessment, governance, patient safety, data quality, transparency, human oversight, third-party management, regulatory applicability, implementation readiness and lifecycle monitoring for artificial intelligence and software used for medical and healthcare purposes.

02 | Digital Therapeutics & Digital Interventions

Evidence, intended use, clinical integration and implementation considerations for software and digitally delivered interventions designed to prevent, manage or treat health conditions, support behavior change or complement established care pathways.

03 | Remote Monitoring & Digital Measures

Connected technologies, digital measures and digital biomarkers used to collect, interpret and apply health information beyond traditional healthcare settings, including consideration of evidence, usability, workflow integration and ongoing monitoring.

04 | Virtual & Connected Care

Care models connecting patients, healthcare professionals, health information and digital technologies across locations and stages of care, including virtual care, remote follow-up and digitally supported care pathways.

05 | Data Governance, Interoperability & Digital Safety

Responsible health data use, data quality, privacy, cybersecurity, interoperability, accountability and technology-related patient safety across Digital Medicine.

Across all themes, we also consider accessibility, health equity, human factors, patient and professional experience, and the needs of different populations and healthcare settings as cross-cutting implementation considerations.

Resources published through Evidence & Insights are developed for professional education, knowledge translation and implementation support.

Where appropriate, each publication will identify its purpose and scope, publication or update date, authorship or review status, key sources, development status, material limitations and intended use.

Regulatory content will distinguish applicable legal and regulatory requirements from international guidance, voluntary standards, professional frameworks and organizational good practice.

Our work is guided by five commitments.

Evidence-Informed

Content draws on relevant research, recognized international guidance and credible scientific, professional and regulatory sources.

Transparent

The purpose, scope, evidence base, development status, limitations and intended use of each resource are communicated as clearly as practical.

Material funding, collaboration or potential conflicts of interest will be disclosed where relevant.

Risk-Proportionate

The depth of evaluation and guidance should reflect the technology’s intended use, claims, context of use and potential impact on patients, healthcare professionals and clinical or organizational decisions.

Locally Relevant

International evidence, standards and guidance are considered in relation to Viet Nam’s healthcare needs, population, infrastructure, workforce, care pathways and applicable regulatory environment.

Current & Revisable

Digital Medicine evolves quickly. Resources may be reviewed, updated, superseded or withdrawn as evidence, technologies, standards and regulatory requirements change.

Digital Medicine Vietnam does not provide regulatory approval, certification, formal conformity assessment, medical advice or legal advice through Evidence & Insights.

OUR PUBLICATION APPROACH

Areas we are focusing on

Evidence, transparency and local relevance

Turning evidence into responsible healthcare practice

Explore our work in evidence, governance, implementation readiness, responsible AI, patient safety, professional education and cross-sector collaboration.

Editorial & Legal Notice